pharmaphorum October 10, 2024
EVERSANA has signed an agreement with Oracle Argus Cloud to add to the features of its pharmacovigilance platform, which helps manufacturers monitor drug safety in an increasingly complex pharmaceutical market.
The partnership has added new functionality to the pharmacovigilance platform, including artificial intelligence-enabled automation, workflow optimisation, and conditional touchless processing which can reduce the manual intervention needed to monitor adverse effects of medicines.
The refinements to its offering are designed to lighten the load of medical affairs teams as they face “increasing caseloads and changing regulations across the life sciences industry,” said pharmaphorum parent EVERSANA in a statement.
The move ties in with the trend in the industry for pharmacovigilance to shift from a reactive activity – which can be...
Today's Sponsors
Today's Sponsor